Sector valuations United Therapeutics Corporation

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2025-07-07 EDT			5-day change	1st Jan Change
290.39 ^USD	-1.39%		+1.06%	-17.70%

06-30	United Therapeutics' Tyvaso to Benefit from Q2 Seasonality, UBS Says	MT
06-30	UBS Adjusts Price Target on United Therapeutics to $385 From $410, Maintains Buy Rating	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
UNITED THERAPEUTICS CORPORATION	10.65x	1.73x	0.87x	3.19x	6.17x	6.4x	-.--%	13.28B
ELI LILLY AND COMPANY	36.74x	26.49x	0.45x	12.16x	27.69x	29.91x	0.76%	701B
JOHNSON & JOHNSON	14.94x	5.08x	0.19x	4.16x	11.47x	12.75x	3.36%	375B
ABBVIE INC.	26.7x	46.4x	0.14x	6.49x	13.52x	13.9x	3.47%	334B
NOVO NORDISK A/S	17.29x	9.96x	1.13x	6.24x	12.44x	13.75x	2.93%	316B
ROCHE HOLDING AG	14.46x	5.35x	0.19x	3.48x	8.64x	9.86x	3.79%	263B
NOVARTIS AG	17.61x	5.35x	0.94x	4.76x	11.59x	12.41x	3.19%	242B
ASTRAZENECA PLC	22.14x	4.88x	0.53x	4.14x	12.18x	12.91x	2.28%	219B
MERCK & CO., INC.	10.37x	3.68x	0.66x	3.36x	7.25x	8.06x	3.98%	203B
AMGEN INC.	22.68x	17.75x	0.31x	5.83x	11.3x	13.21x	3.22%	160B
PFIZER, INC.	12x	1.59x	0.24x	2.92x	7.22x	8.36x	6.73%	144B
GILEAD SCIENCES, INC.	18.53x	6.16x	0.01x	5.24x	9.57x	11.56x	2.91%	139B
SANOFI	11.24x	1.28x	0.18x	2.43x	7.86x	8.67x	4.97%	120B
VERTEX PHARMACEUTICALS INCORPORATED	30.52x	5.97x	-0.04x	9.14x	19.2x	20.18x	-.--%	118B
BRISTOL-MYERS SQUIBB COMPANY	10.46x	4.61x	-0.05x	2.77x	7.23x	7.61x	5.28%	95.49B
CHUGAI PHARMACEUTICAL CO., LTD.	26.88x	5.86x	2.14x	8.95x	17.63x	18.43x	3.36%	81.13B
GSK PLC	9.91x	3.87x	0.08x	2.18x	6.45x	7.37x	4.63%	77.55B
JIANGSU HENGRUI MEDICINE CO., LTD.	47.2x	6.36x	3.68x	10.27x	38.06x	41.3x	0.43%	49.34B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	28.52x	1.02x	0.22x	2.35x	8.65x	21.82x	4.5%	47.98B
Average	20.47x	8.60x	0.62x	5.27x	12.85x	14.66x	3.15%	194.74B
Weighted average by Cap.	22.01x	13.53x	0.49x	6.26x	14.53x	15.98x	2.92%